Clinical Evidence: What 1 mg Semaglutide Can Achieve Landmark trials including STEP 2 showed that participants using 1 mg weekly semaglutide experienced approximately 11% body weight reduction over 68 weeks, significantly outperforming standard care and diet-only interventions
Inhibiting pyroptosis with Caspase-1 inhibitor VX-765 effectively suppressed the occurrence of pyroptosis in HK-2 cells, as well as the tubular damage, renal inflammation and DKD progression in diabetic mice (168)
\High Responder Rate: ~60% of patients achieved 20% weight loss
By partnering with Ivologist, you ensure that your compounded Semaglutide is sourced from a trusted provider, setting the foundation for a successful treatment plan
Medical expertise We specialize in hormone and metabolic health
Friedrichsen, M., Breitschaft, A., Tadayon, S., Wizert, A., & Skovgaard, D